• D1.1 – Kick-off WP meeting and report”, due month 6, Restricted access – available to GP-TCM members only
  • D1.2 – Website building and maintenance”, due month 6, Restricted access – available to GP-TCM members only
  • D1.3 – Priority list of plants”, due month 6, Restricted access for full report – available to GP-TCM members only / Public access for report summary – available upon request via email [email protected]
  • D1.4 – Design of a database linking Latin binomial names of CHM with other names and information…”, due month 6, Restricted access for full report – available to GP-TCM members only / Public access for report summary – available upon request via email [email protected]
  • D1.5 – Several web-based workshops will be held to establish a workable system for the quality control of plants, quarterly after the kick-off meeting, Restricted access – available to GP-TCM members only.
  • D1.6 – Procedures and recommendations of good practice in quality control of CHM“, due month 18, Public deliverable: GP-TCM Deliverable D1.6 Report
  • D1.7 – Report on the knowledge gaps about quality control of the priority list of plants“, due month 24, Public deliverable: GP-TCM Deliverable D1.7 Report
  • D1.8 – Identify availability of vouchered collections of different species used in TCM, along with DNA samples and chemical fingerprints associated with different processing and extracting methods, associated substitutes and adulterants“, due month 24, Public deliverable: GP-TCM Deliverable D1.8 Report
  • D1.9 – An overview report for the Final Conference with recommendations for the future“, due month 30, Restricted access – available to GP-TCM members only
  • D1.10 – A final report that incorporates discussions, recommendations, issues and challenges raised at the Final Conference“, due month 36, Public deliverable: GP-TCM Deliverable D1.10 Report
  • D1.11 – Scientific papers on challenges and solutions to the quality control of CHM submitted for publication“, due month 36, Public deliverable: GP-TCM Deliverable D1.11 Report
  • D2.1 – Kick-off WP meeting and report”, due month 6, Restricted access – available to GP-TCM members only
  • D2.2 – Report on findings from workshop including priority list of CHM”, due month 6, Restricted access – available to GP-TCM members only
  • D2.3 – Establishment of an interactive website containing evolving information produced during the project and open to the Consortium”, due month 6
  • D2.4 – Report summarising techniques and standards employed for the analysis of simple and complex…”, due month 6, Restricted access for full report – available to GP-TCM members only / Public access for report summary – available upon request via email jandirk.sendker [at] uni-muenster [dot] de
  • D2.5 – Report summarising techniques and standards employed for the preparation of extracts used in TCM”, due month 12, Restricted access for full report – available to GP-TCM members only / Public access for report summary – available upon request via email jandirk.sendker [at] uni-muenster [dot] de
  • D2.6 – Workshop targeting selection of minimum acceptable standards for extract preparation, purification and component analysis”, due month 12, Restricted access – available to GP-TCM members only
  • D2.7- Report on findings from workshop including minimum acceptable standards for extract preparation, purification and component analysis”, due month 12, Public deliverable: GP-TCM Deliverable D2.7 Report
  • D2.8 – Workshop reviewing best practice methods used for information analysis“, due month 18, Restricted access – available to GP-TCM members only
  • D2.9 – Report on workshop and recommendations for best practice in information analysis for fingerprinting and component analysis in CHM“, due month 24, Public deliverable: GP-TCM Deliverable D2.9 Report
  • D2.10 – Comprehensive report on the methodology used in the analysis of ‘priority list preparations’“, due month 24, Public deliverable: GP-TCM Deliverable D2.10 Report
  • D2.11 – Workshop reviewing the correlation of methodology used in the analysis of priority list with best practice standards recommended in this study’“, due month 30, Public deliverable: GP-TCM Deliverable D2.11 Report
  • D2.12 – Report on workshop and recommendations highlighting the status of the information and identifying non-standard areas; recommendations for research agenda going forward“, due month 30, Public deliverable: GP-TCM Deliverable D2.12 Report
  • D2.13 – Presentation of findings at the conference planned in work package“, due month 36, Public deliverable: GP-TCM Deliverable D2.13 Report
  • D2.14 – Final report including complete database of experts and distribution of skills“, due month 36, Public deliverable: GP-TCM Deliverable D2.14 Report
  • D2.15 – Review papers published in scientific journals“, due month 36, Public deliverable: GP-TCM Deliverable D2.15 Report
  • D3.1 – Kick-off WP meeting and report”, due month 6, Restricted access – available to GP-TCM members only
  • D3.2 – Website building and maintenance”, due month 6, Restricted access – available to GP-TCM members only
  • D3.3 – Systemic literature review and translation”, due month 6, Restricted access – available to GP-TCM members only
  • D3.4 – Several workshops will be promoted among the partners and with external collaborators to compare and discuss results, and to elaborate a final monograph”, due months 12, 24,  and 30, Restricted access – available to GP-TCM members only
  • D3.5 – A new research agenda will be developed to address the gaps in knowledge and the next steps in coordination might be planned”, due month 12, Restricted access – available to GP-TCM members only
  • D3.6 – Focus meeting – consumer based; consensus document; web site updated; continued scientific exchange via EMEA (EU), State Administration of TCM of China and State Food and Drug Administration of China, FDA (USA)“, due month 24, Restricted access – available to GP-TCM members only
  • D3.7 – Prepare a programme for the Final Conference“, due month 36, Restricted access – available to GP-TCM members only
  • D3.8 – A report published in the Final Conference“,  due month 36, Public deliverable: GP-TCM Deliverable D3.8 Report
  • D3.9 – Review papers published in scientific journals“, due month 36, Public deliverable: GP-TCM Deliverable D3.9 Report
  • D4.1 – Kick-off WP meeting”, due month 6, Restricted access – available to GP-TCM members only
  • D4.2 – Kick-off meeting report: Agreed schedule of the task assignment of subgroups, due month 6, Restricted access – available to GP-TCM members only
  • D4.3 – Website building and maintenance”, due month 6
  • D4.4 – Report of the discussion group on biological target oriented database”, due month 12, Public deliverable: GP-TCM Deliverable D4.4 report
  • D4.5 – Biological target oriented database for in vitro research on CHM”, due month 12, Public deliverable: GP-TCM Deliverable D4.5 report
  • D4.6 – Report on quality criteria and scoring of the CHM database”, due month 12, Public deliverable: GP-TCM Deliverable D4.6 report
  • D4.7 – Update of CHM target oriented database with quality scores”, due month 12, Public deliverable: GP-TCM Deliverable D4.7 report
  • D4.8 – Handbook on good practice in the reporting of CHM experimental work“, due month 18, Public deliverable: GP-TCM deliverable D4.8 report
  • D4.9 – Report of the discussion group on criteria for evaluating data suggestive of molecular mechanisms of action of CHM“, due month 18, Public deliverable: GP-TCM deliverable D4.9 report
  • D4.10 – Update of the CHM target oriented database with molecular mechanism evaluations“, due month 18, Public deliverable: GP-TCM deliverable D4.10 report
  • D4.11 – Report on analysis of existing protein databases and software for in silico studies of phytocomplexes“, due month 24, Public deliverable: GP-TCM deliverable D4.11 report
  • D4.12 – Proceedings of the interdisciplinary consensus meeting on in silico tools for CHM research“, due month 24, Public deliverable: GP-TCM deliverable D4.12 report
  • D4.13 – Handbook of guidelines for using in silico tools in CHM research“, due month 24, Public deliverable: GP-TCM deliverable D4.13 report
  • D4.14 – Report of the discussion group on the use of functional genomic techniques for in vitro CHM research“, due month 24, Public deliverable: GP-TCM deliverable D4.14 report
  • D4.15 – Report on technical, economical, analytical aspects of the use of functional genomics in in vitro research of CHM“, due month 30, Public deliverable: GP-TCM deliverable D4.15 report
  • D4.16 – Handbook for using functional genomics techniques in in vitro CHM research“, due month 36, Public deliverable: GP-TCM Deliverable D4.16 Report
  • D4.17 – Report in the Final Conference” – due month 36, Public deliverable: GP-TCM Deliverable D4.17 Report
  • D4.18 – Submission of review papers for publication“, due month 36, Public deliverable: GP-TCM deliverable D4.18 report
  • D5.1 – Kick-off WP meeting and report”, due month 6, Restricted access – available to GP-TCM members only
  • D5.2 – Website building and maintenance”, due month 6
  • D5.3 – Building of an expert network in CHM in animal models of disease”, due month 6, Restricted access – available to GP-TCM members only
  • D5.4 – Review of literature relating to CHM in animal models of disease and elaboration of a priority list for further research”, due months 12, 18 and 24, Public deliverable: GP-TCM Deliverable D5.4 – D5.6 (VOLs I & II) Reports & GP-TCM Deliverable D5.4 – D5.6 (VOL III) Report
  • D5.5 – Circulation and discussion of the report (Review of literature relating to CHM in animal models of disease)”, due month 12, Public deliverable: GP-TCM Deliverable D5.4 – D5.6 (VOLs I & II) Reports & GP-TCM Deliverable D5.4 – D5.6 (VOL III) Report
  • D5.6 – Report on agreed conclusions of the review of literature”, due month 12, Public deliverable: GP-TCM Deliverable D5.4 – D5.6 (VOLs I & II) Reports & GP-TCM Deliverable D5.4 – D5.6 (VOL III) Report
  • D5.7 – Elaboration of a priority list of CMH for future research in CMH in animal models“, due month 18, Public deliverable: GP-TCM deliverable D5.7 report
  • D5.8 – Report on agreed conclusions on the efficacy of CMH in animal models“, due month 18, Public deliverable: GP-TCM deliverable D5.8 report
  • D5.9 – Recommendations on the application of functional genomic studies and chemical synthesis to the study of CHM in animal models of disease “, due month 24, Public deliverable: GP-TCM Deliverable D5.9 report
  • D5.10 – Recommendations on best practice in CHM in animal models of disease“, due month 24, Public deliverable: GP-TCM Deliverable D5.10 report
  • D5.11 – Report on the problems carrying out investigations of CMH in animal models“, due month 30, Public deliverable: GP-TCM Deliverable D5.11 report
  • D5.12 – Future research priority areas in animal studies of CHM“, due month 30, Public deliverable: GP-TCM Deliverable D5.12 report
  • D5.13 – Presentation of findings at the conference planned in work package and discussion with invited experts from the network“, due month 36, Public deliverable: GP-TCM Deliverable D5.13 Report
  • D5.14 – Final report published in scientific journals“, due month 36, Public deliverable: GP-TCM Deliverable D5.14 Report
  • D6.1 – Kick-off WP meeting and report”, due month 6, Restricted access – available to GP-TCM members only
  • D6.2 – Building of a clinical expert network in CHM in all the 11 EU Member States in this Consortium”, due month 6, Restricted access – available to GP-TCM members only
  • D6.3 – Inauguration of website on clinical use of CHM and the application of functional genomics to foster debate”, due month 6, Restricted access – available to GP-TCM members only
  • “D6.4 – Questionnaire designed and carried about the concerns and attitude of doctors, nurses, patients and the public on possible future clinical trials of CHM and acupuncture (in partnership with WP8)”, due month 12, Restricted access – available to GP-TCM members only
  • D6.5 – Review of literature relating to CHM in clinical studies and elaboration of areas for further research. Report on the reviewed literature relating to CHM”, due month 12, Public deliverable: GP-TCM deliverable D6.5 report
  • D6.6 – Report on agreed conclusions of the review of literature”, due month 12, Public deliverable:  GP-TCM deliverable D6.6 report
  • D6.7 – Focus list of clinical areas and approaches to be supported written“, due month 18, Restricted access – available to GP-TCM members only
  • D6.8 – Recommendations on the application of functional genomic studies to the study of CHMs in patients“, due month 24, Public deliverable: GP-TCM deliverable D6.8 report
  • D6.9 – Presentation of findings at the Final Conference on clinical functional genomic approaches to CHM“, due month 36, Public deliverable: GP-TCM Deliverable D6.9 Report
  • D6.10 – Final report published in scientific journals“, due month 36, Public deliverable: GP-TCM Deliverable D6.10 Report
  • D7.1 – Kick-off WP meeting and report”, due month 6, Restricted access – available to GP-TCM members only
  • D7.2 – Website building and maintenance”, due month 6, Restricted access – available to GP-TCM members only
  • D7.3 – Circulation of draft observations and comments”, due month 12, Restricted access – available to GP-TCM members only
  • D7.4 – Release of observations as draft guidelines for discussion with EMEA and FDA”, due months 18, 24 and 30, Restricted access for full report – available to GP-TCM members only / Public access for report summary – is available upon request via email [email protected]
  • D7.5 – Submission of agreed guidelines for publication”, due months 18, 24 and 30, Public deliverable: GP-TCM Deliverable D7.5 Report
  • D7.6 – Publication on utility of functional genomics in CHM research and development“, due month 24, Public deliverable: GP-TCM Deliverable D7.6 Report
  • D7.7 – Programme on R&D of CHM for the Final Conference and submission for publication“, due month 36, Public deliverable: GP-TCM Deliverable D7.7 Report
  • D7.8 – Web-based fora on R&D of CHM”, quarterly, Restricted access for full report – available to GP-TCM members only / Public access for report summary – available upon request via email [email protected]
  • D8.1 – Kick-off WP meeting and report”, due month 6, Restricted access – available to GP-TCM members only
  • D8.2 – Website building and maintenance”, due month 6, Restricted access – available to GP-TCM members only
  • D8.3 – Questionnaire designed and carried about the concerns and attitude of doctors, nurses, patients and the public on possible future clinical trials of acupuncture and CHM”, due month 12, Restricted access – available to GP-TCM members only
  • D8.4 – Teleconference to discuss major problems or topics in acupuncture in connection of functional genomics”, quarterly, Restricted access – available to GP-TCM members only
  • D8.5 – Primary report on pitfalls and solutions for functional genomics studies of acupuncture“, due month 24, Public deliverable: GP-TCM deliverable D8.5 report
  • D8.6 – Present work in final conference“, due month 36, Public deliverable: GP-TCM Deliverable D8.6 Report
  • D8.7 – Final report on functional genomics studies of acupuncture and moxibustion“, due month 36, Public deliverable: GP-TCM Deliverable D8.7 Report
  • D8.8 – Submission of the report for publication“, due month 36, Public deliverable: GP-TCM Deliverable D8.8 Report
  • D9.1 – Invitations to the conference“, due month 24, Public deliverable: GP-TCM deliverable D9.1 report
  • D9.2 – Host of the conference“, due month 36, Public deliverable, meeting information available upon request via email [email protected]
  • D9.3 – Evaluation of the conference based on beneficiaries satisfaction“, due month 38, Public deliverable: GP-TCM Deliverable D9.3 Report
  • D9.4 – Production and submission of conference proceedings to a scientific journal“, due month 42, Public deliverable: GP-TCM Deliverable D9.4 Report
  • D9.5 – Production of attendee database and preferred roles, actions and contacts to maintain links for partnerships and coordination“, due month 40, Public deliverable: GP-TCM Deliverable D9.5 Report
  • D10.1 – Organisation of initial coordination web meeting for all beneficiary…”, due month 6, Restricted access – available to GP-TCM members only
  • D10.2 – Organising an ICUK-sponsored consortium kick-off meeting”, due month 6, Restricted access – available to GP-TCM members only
  • D10.3 – Launch EU FP7 Project Collaboration Website”, due month 6, Restricted access – available to GP-TCM members only
  • D10.4 – Quarterly Management and Science Meetings online or face-to-face”, quarterly, Restricted access – available to GP-TCM members only
  • D10.5 – Reports to the EC“, due months 18 and 42, Restricted access – available to GP-TCM members only.
  • D10.6 – Support the Final conference“, due month 36, Public deliverable: GP-TCM Deliverable D10.6 Report
  • D10.7 – The European Society of TCM Research“, due month 36, Public deliverable: GP-TCM Deliverable D10.7 Report
  • D10.8 -The full final report“, due month 42, Public deliverable, available upon request via email [email protected]
  • D10.9 -Dissemination and public outreach activities“, due month 42, Public deliverable, available upon request via email [email protected]

Loading